Rory QuirkieFeb 2, 20222 minAalto Bio Reagents Announces its New SARS-CoV-1 Spike Protein S1 Domain (Korean Outbreak Strain)Dublin, Ireland – February 2nd 2022 – Aalto Bio Reagents ltd. a leading developer of critical raw materials and reagents for the...
Rory QuirkieDec 14, 20212 minAalto Bio Reagents Announces its SARS-CoV-2 Nucleocapsid Protein and...Aalto Bio Reagents announces its Sars nCOV 2 Nucleocapsid protein and Monoclonals to NP are capable of detecting the conserved...
Kellie MeadeJun 14, 20212 minAalto Bio Reagents Features in Country Reports Article for its Rapid Response to the COVID-19 CrisisDublin, Ireland - 14th June 2021 (Newsweek.com) - One of the oldest privately held biotech companies present in Ireland is Aalto Bio...
Kellie MeadeMar 3, 20212 minAalto Bio Reagents Relaunches World Renowned Affinity-Purified Anti-HIV-1 gp120 AntibodyDublin, Ireland – 2nd March 2021 - Aalto Bio Reagents is delighted to announce the re-launch of their world renowned affinity-purified...